Positive context积极背景
Stocks股票 / Health Care / CRSP
CRISPR Therapeutics AG · Health Care
CRSP US listed · USD美股 · 美元
Health Care
Russell 2000罗素2000
Speculative / unprofitable投机／未盈利
$54.00
-$3.34 · -5.82%
52w low52周低 $42.89high高 $79.00
Neutral — no clear edge中性 — 无明显优势
The bottoming setup is not yet confirmed (price still below the 10-day average) and the 3-day/weekly momentum has crossed down — momentum is fading before the…筑底形态尚未确认（价格仍位于 10 日均线下方），且3 日/周线动量已向下交叉——动量在形态完成前已开始衰竭。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
As of 2026-10-07截至 2026-10-07
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-10-07
Momentum (RSI 14)动量（RSI 14）
46
Neutral zone中性区域
vs 50-day average相对50日均线
-1.3% below下方
Below trend跌破趋势
vs 200-day average相对200日均线
+1.3% above上方
Long trend up长期向上
Volatility波动率
35th percentile第35百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-11-0933
Mixed — beat 2 of last 4 quarters表现不稳 — 近 4 季中 2 季超预期
Post-earnings drift: +7.9% (20d)财报后漂移：+7.9%（20日）
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度（近几个季度） · average平均 -1.4%
Financials财务数据
fiscal years财年Revenue营业收入
$3.5M2025
20202025
5-yr growth5年复合增速 37.3%
Earnings per share每股收益
$-6.472025
20202025
Free cash flow自由现金流
-$345.9M2025
20202025
Operating margin营业利润率
-18933.6%
Net margin净利率
-16569.8%
FCF margin自由现金流利润率
-9829.5%
Balance-sheet quality财务体质 1/7
Return on equity股本回报率 -30%
Watch关注
Leverage杠杆
Current ratio流动比率13.32
Capital allocation资本配置
Stock-based comp股权薪酬$72.5M
Share count change (1y)股数变化（1年）+11.8%
Debt coming due到期债务
SEC filingsSEC 文件Its filings are available, but they do not break debt down by the year it comes due — every bucket below is unreported.已获取该公司的 SEC 文件，但文件中未按到期年度拆分债务 —— 以下各区间均未披露。
Next 12 months未来12个月
not reported未披露
Year 2第2年
not reported未披露
Year 3第3年
not reported未披露
Year 4第4年
not reported未披露
Year 5第5年
not reported未披露
After year 55年以后
not reported未披露
Not every company reports a year-by-year schedule. Nothing is being estimated in its place.并非所有公司都会披露逐年到期安排；此处不作任何估算替代。
Cash reported at 2025-12-31: $347559000.截至 2025-12-31 披露的现金：$347559000。 At the cash-burn pace reported over 2025-01-01 to 2025-12-31, that cash represented about 12.1 months. This scenario excludes debt payments and future financing.按 2025-01-01 至 2025-12-31 期间披露的现金消耗速度，该现金约对应 12.1 个月。此情景不包括债务偿还与未来融资。
Capital-need coverage is partial; incomplete or incompatible filing inputs are not combined.资本需求覆盖信息不完整；不会合并不完整或不兼容的报告数据。
Any available cash-flow scenario is context only. Missing or incompatible inputs are not replaced with zero or a financing forecast.可用现金流情景仅供参考；缺失或不兼容的输入不以零值或融资预测替代。
Sources and cash-flow calculation来源与现金流计算
Annual period年度区间 2025-01-01 — 2025-12-31 · USD · 10-K · 0001193125-26-048957 · Filed提交日期 2026-02-12.
Cache acquired缓存获取时间: 2026-09-23T08:01:14.002074+00:00 · Evaluated as of评估截至 2026-10-07.
- Reported operating cash flow已披露经营活动现金流: $-345014000
- Reported equipment spending (capex outflow)已披露设备支出（资本开支流出）: $914000
- Derived free cash flow (operating cash flow minus capex)计算所得自由现金流（经营现金流减资本开支）: $-345928000
Cash is the reported balance at period end. The runway scenario holds this annual cash-flow pace constant and excludes debt payments, restricted-cash adjustments and future financing.现金为期末已披露余额。现金跑道情景假设本年度现金流速度保持不变，不包括债务偿还、受限现金调整与未来融资。
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
News新闻
1 recent stories — mixed1 篇最新报道，多空参半
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
CRSP daily MACD crossed downCRSP 日线MACD下穿
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$12.4M net (1 buyers, 4 sellers)-$12.4M 净值（1 买家，4 卖家）
Signal history信号历史
engine events引擎事件
BUY ZONE → BOTTOMING买入区 → 筑底中
BUY SETUP. Buyers rejected the 2026-09-11 low (swing low printed) but price hasn't reclaimed its 10-day average — first box ticked, not all买入预备。买方拒绝了 2026-09-11 的低点（摆动低点已现），但价格尚未收复 10 日均线——第一项条件达成，并非全部
Oct 6, 2026
CRSP daily MACD crossed downCRSP 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $54.00.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$54.00。
Oct 5, 2026
BOTTOMING → BUY ZONE筑底中 → 买入区
BUY买入
Oct 5, 2026
CRSP daily MACD crossed upCRSP 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $57.34.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$57.34。
Oct 2, 2026
NEARING A LOW → BOTTOMING接近低点 → 筑底中
BUY SETUP买入预备
Sep 30, 2026
UPTREND → NEARING A LOW上涨趋势 → 接近低点
GET READY准备
Sep 25, 2026
BUY ZONE → NEARING A LOW买入区 → 接近低点
GET READY准备
Sep 25, 2026
CRSP daily MACD crossed downCRSP 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $54.23.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$54.23。
Sep 24, 2026
NEARING A HIGH → BUY ZONE接近高点 → 买入区
BUY买入
Sep 23, 2026
Golden cross on CRSPCRSP 金叉
The 50-day average crossed above the 200-day — a slow, widely-watched bullish trend signal. $55.76.50日均线上穿200日均线 — 一个滞后但广受关注的看多趋势信号。$55.76。
Showing the last 15 of显示最近15条，共 186 signals条信号
Company profile公司档案
Watch items — what could change the story关注项 — 可能改变故事的因素
- Capital intensity rising
Recent news最新动态
CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade
Zacks Investment Research · 2026-10-06
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -3.6% | +1.9% |
| 1 Month近1月 | -3.2% | +1.4% |
| 3 Months近3月 | -8.8% | +4.8% |
| 6 Months近6月 | +4.4% | +15.2% |
| Year to date年初至今 | +0.4% | +14.9% |
| 1 Year近1年 | -23.1% | +17.3% |
Trading information交易信息
Volatility rank波动率分位
35th pctile
EPS (trailing)每股收益
$-6.06
Off 52-week high距52周高点
-29.7%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $719,000 | $915M | $1M | $371M | $37M | $4M |
| EPS每股收益 | $-5.29 | $4.70 | $-8.36 | $-1.94 | $-4.34 | $-6.47 |
| Free cash flow自由现金流 | $-257M | $457M | $-533M | $-270M | $-145M | $-346M |
| Gross margin毛利率 | — | — | — | — | — | — |
| Net margin净利率 | -48520.9% | 41.3% | -54271.7% | -41.4% | -981.5% | -16569.8% |
| FCF margin自由现金流利润率 | -35705.7% | 50.0% | -44484.9% | -72.7% | -387.7% | -9855.5% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$4M
Net income净利润
$-582M
Operating cash flow经营现金流
$-345M
Total assets总资产
$2.3B
Shareholder equity股东权益
$1.9B
Shares outstanding总股本
0.10B
Returns & growth回报与增长
Return on equity股本回报率
-30.3%
Return on assets资产回报率
-25.7%
Asset growth资产增速
+1.0%
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量：盈利有现金支撑
- Working capital: receivables +17261% vs sales +5090% — receivables outpacing sales, revenue-quality risk营运资本：应收 +17261% 对销售 +5090%——应收快于销售，营收质量风险
- Capital discipline: share count +29.7% over 6 years (dilution)资本纪律：股本 6 年增加 29.7%（稀释）
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
46
RSI (2-day)RSI（2日）
23
vs 20-day average相对20日均线
-1.7%
vs 50-day average相对50日均线
-1.3%
vs 200-day average相对200日均线
+1.3%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
below signal位于信号线下方
Timeframe alignment多周期共振
Daily日线
momentum down — fresh downturn动能向下——刚刚转弱
3-day3日线
momentum down — fresh downturn动能向下——刚刚转弱
Weekly周线
momentum up动能向上
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range state波幅状态
Fired_DownFIRED_DOWN
Days compressed已压缩天数
8
Range width percentile波幅宽度分位
14/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $-0.94 | $-1.10 | +14.6% |
| Mar 2026 | $-1.28 | $-1.14 | -12.3% |
| Dec 2025 | $-1.37 | $-1.15 | -19.1% |
| Sep 2025 | $-1.17 | $-1.32 | +11.4% |
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$12.4M
Insider buyers vs sellers内部人买家vs卖家
1 : 4
Recent fund flows近期基金流向
SPDR S&P BiotechSPDR S&P Biotech
accumulating持续增持
ROBO Global Healthcare Technology & InnovationROBO Global Healthcare Technology & Innovation
trimming减持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。